His lab is working on refining the alanine-scanning assay to some essential residues which can precisely distinguish among fibrils from neurodegenerative tauopathies. He envisions using this streamlined assay for postmortem neuropathological prognosis, and possibly for blood screening of tauopathies.You’re also about to want to shield your laptop